What is the first‑line antibiotic for cholera and its recommended dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Line Antibiotic for Cholera

Azithromycin is the first-line antibiotic for cholera, administered as a single oral dose of 20 mg/kg (up to 1 g maximum) for children and 1 g for adults, but antibiotics should only be given to patients with severe dehydration—fluid resuscitation remains the cornerstone of cholera management. 1

Antibiotic Selection and Dosing

First-Line: Azithromycin

  • Single-dose azithromycin (20 mg/kg for children, 1 g for adults) is the WHO-recommended first-line agent based on superior clinical outcomes and ease of administration 2, 1.
  • Azithromycin shortens diarrhea duration by more than 1 day compared to ciprofloxacin (mean difference -32.4 hours; 95% CI -62.9 to -1.95 hours) and by approximately half a day compared to erythromycin 2, 3.
  • Clinical success rates are significantly higher with azithromycin (RR 1.34; 95% CI 1.16-1.54) 2.
  • The single-dose regimen improves compliance, making it especially valuable in epidemic settings where treatment adherence is challenging 2, 1.

Second-Line Options

  • Doxycycline is the preferred second-line agent when azithromycin is unavailable or contraindicated 2, 1.

    • Adult dosing: single 300 mg dose 4, 5, 1, 6.
    • Pediatric dosing: 4-6 mg/kg (up to 300 mg) as a single dose for children >8 years 4, 5, 7.
    • Single-dose doxycycline (300 mg) is as effective as multiple-dose tetracycline in reducing stool output and duration of diarrhea 6.
  • Ciprofloxacin is an alternative second-line agent 4, 2, 1.

    • Adult dosing: 500 mg orally twice daily for 3 days or single-dose fluoroquinolone 4.
    • Pediatric dosing: 15 mg/kg twice daily for 3 days 8.

Historical Context: Tetracycline

  • Tetracycline was historically the drug of choice but has been relegated due to increasing resistance 2, 1, 9.
  • Tetracycline resistance in Vibrio cholerae O1 strains has reduced its effectiveness, prompting the shift to azithromycin as first-line 1, 9.
  • If tetracycline is used: 500 mg every 6 hours for 72 hours (adults) or 50 mg/kg/day divided every 6 hours for 72 hours (children) 5.

Indications for Antibiotic Use

  • Antibiotics should be administered ONLY to patients with severe dehydration 2, 1.
  • Patients with mild-to-moderate dehydration do not require antibiotics and should receive oral rehydration solution (ORS) alone 2, 1.
  • Antibiotics reduce stool volume by 50% (ROM 0.5; 95% CI 0.45-0.56), decrease rehydration fluid requirements by 40% (ROM 0.60; 95% CI 0.53-0.68), and shorten fecal excretion of vibrios by almost 3 days 3.
  • Rapid fluid replacement remains the primary therapy for all cholera patients—antibiotics are adjunctive 2, 1, 9.

Clinical Algorithm for Antibiotic Selection

  1. Assess hydration status first: Severe dehydration (sunken eyes, skin pinch >2 seconds, lethargy/unconsciousness) warrants antibiotics 2, 1.
  2. If severe dehydration present:
    • First choice: Azithromycin single dose (20 mg/kg up to 1 g) 1.
    • If azithromycin unavailable: Doxycycline single dose (300 mg adults, 4-6 mg/kg children >8 years) 1, 6.
    • If both unavailable: Ciprofloxacin 500 mg twice daily for 3 days (adults) or 15 mg/kg twice daily for 3 days (children) 4, 8.
  3. If mild-to-moderate dehydration: ORS alone, no antibiotics 2, 1.

Critical Pitfalls to Avoid

  • Do NOT use doxycycline or tetracycline as empiric first-line therapy in regions with documented tetracycline resistance 1, 9.
  • Do NOT prescribe antibiotics without ensuring adequate rehydration first—fluid therapy is the cornerstone of management 2, 1, 9.
  • Do NOT use antibiotics for patients with mild-to-moderate dehydration—this promotes unnecessary resistance 2, 1.
  • Do NOT use multiple-dose regimens when single-dose azithromycin is available—compliance is superior with single-dose therapy 2, 1.
  • Avoid tetracycline in children <8 years due to dental staining risk 5, 7.

Resistance Considerations

  • Increasing resistance to tetracyclines and fluoroquinolones has driven the shift to azithromycin 2, 1, 9.
  • Local antibiotic susceptibility patterns should guide therapy when available 5, 9.
  • Azithromycin resistance remains low globally, supporting its use as first-line 9.

References

Guideline

WHO 2024 Cholera Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Antimicrobial drugs for treating cholera.

The Cochrane database of systematic reviews, 2014

Guideline

practice guidelines for the management of infectious diarrhea.

Clinical Infectious Diseases, 2001

Research

Single-dose doxycycline for cholera.

Antimicrobial agents and chemotherapy, 1978

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.